SCHEMBL8205852

SCHEMBL8205852

C=CCN1C(=O)/C(=C\c2ccc3c(c2)CCC3)SC1=S

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B3 P37058 1/20 0.62
▸ MYC P01106 3/20 0.61
▸ MAX P61244 3/20 0.61
▸ ALDH1A1 P00352 5/20 0.59
▸ SMN1; SMN2 Q16637 4/20 0.59
▸ PDE4B Q07343 1/20 0.57
▸ SYK P43405 1/20 0.53
▸ DNM1 Q05193 1/20 0.52
▸ MEN1 O00255 5/20 0.49
▸ KMT2A Q03164 5/20 0.49
▸ MAPK1 P28482 3/20 0.48
▸ MAPT P10636 2/20 0.48
▸ GAA P10253 2/20 0.47
▸ CTRC Q99895 1/20 0.46
▸ POLB P06746 2/20 0.46
▸ HSP90AA1 P07900 1/20 0.44
▸ CASP3 P42574 1/20 0.44
▸ SENP8 Q96LD8 1/20 0.44
▸ SENP7 Q9BQF6 1/20 0.44
▸ SENP6 Q9GZR1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8205853 1.00 HSD17B3 (0.62) HSD17B3MYCMAXALDH1A1SMN1; SMN2
SCHEMBL1124983 0.79 MYC (0.74) HSD17B3MYCMAXALDH1A1SMN1; SMN2
SCHEMBL1124985 0.79 MYC (0.74) HSD17B3MYCMAXALDH1A1SMN1; SMN2
SCHEMBL18103053 0.78 MAPK1 (0.72) HSD17B3MYCMAXALDH1A1SMN1; SMN2
SCHEMBL20005672 0.78 MAPK1 (0.72) HSD17B3MYCMAXALDH1A1SMN1; SMN2
SCHEMBL20816065 0.76 MYC (1.00) HSD17B3MYCMAXALDH1A1SMN1; SMN2
SCHEMBL20816067 0.76 MYC (1.00) HSD17B3MYCMAXALDH1A1SMN1; SMN2
SCHEMBL8308291 0.74 PDE4B (0.78) HSD17B3MYCMAXALDH1A1SMN1; SMN2
SCHEMBL8308289 0.74 PDE4B (0.78) HSD17B3MYCMAXALDH1A1SMN1; SMN2
SCHEMBL18103074 0.73 SYK (0.74) HSD17B3MYCMAXALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000032598-A9 METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY DISEASES UTILIZING INHIBITORS OF TUMOR NECROSIS FACTOR ACTIVITY STRUCTURAL BIOINFORMATICS INC (US) 2000-11-30 — — WO claimed
WO-2000032598-A9 METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY DISEASES UTILIZING INHIBITORS OF TUMOR NECROSIS FACTOR ACTIVITY STRUCTURAL BIOINFORMATICS INC (US) 2000-11-30 — — WO disclosed
WO-2000032598-A1 METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY DISEASES UTILIZING INHIBITORS OF TUMOR NECROSIS FACTOR ACTIVITY STRUCTURAL BIOINFORMATICS INC. (US) 2000-06-08 — — WO disclosed
Send feedback